110 related articles for article (PubMed ID: 15638221)
21. Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients 'on' and 'off' atorvastatin for short time intervals.
Thomas MK; Narang D; Lakshmy R; Gupta R; Naik N; Maulik SK
Cardiovasc Drugs Ther; 2006 Feb; 20(1):37-44. PubMed ID: 16534549
[TBL] [Abstract][Full Text] [Related]
22. Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.
Huptas S; Geiss HC; Otto C; Parhofer KG
Am J Cardiol; 2006 Jul; 98(1):66-9. PubMed ID: 16784923
[TBL] [Abstract][Full Text] [Related]
23. Atorvastatin increases myocardial indices of oxidative stress in a porcine model of hypercholesterolemia and chronic ischemia.
Sodha NR; Boodhwani M; Ramlawi B; Clements RT; Mieno S; Feng J; Xu SH; Bianchi C; Sellke FW
J Card Surg; 2008; 23(4):312-20. PubMed ID: 18598320
[TBL] [Abstract][Full Text] [Related]
24. [Oxidation stress, insulin resistance and endothelial dysfunction during the treatment of hyperlipidaemia].
Zeman M; Vecka M; Stopka P; Zahin M; Tvrzická E; Stanková B; Vareka T; Janíková L; Zák A
Cas Lek Cesk; 2006; 145(12):923-8. PubMed ID: 17323614
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
Dogra G; Irish A; Chan D; Watts G
Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020
[TBL] [Abstract][Full Text] [Related]
26. The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia--a pilot study involving serial sampling.
Goudevenos JA; Bairaktari ET; Chatzidimou KG; Milionis HJ; Mikhailidis DP; Elisaf MS
Curr Med Res Opin; 2001; 16(4):269-75. PubMed ID: 11268711
[TBL] [Abstract][Full Text] [Related]
27. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
[TBL] [Abstract][Full Text] [Related]
28. Atorvastatin protects against ischemia-reperfusion injury in fructose-induced insulin resistant rats.
Prakash P; Khanna V; Singh V; Jyoti A; Jain M; Keshari RS; Barthwal MK; Dikshit M
Cardiovasc Drugs Ther; 2011 Aug; 25(4):285-97. PubMed ID: 21671014
[TBL] [Abstract][Full Text] [Related]
29. Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.
Bayés B; Granada ML; Lauzurica R; Pastor MC; Navarro M; Bonet J; Llopis MA; Romero R
Transplant Proc; 2005 Nov; 37(9):3808-12. PubMed ID: 16386546
[TBL] [Abstract][Full Text] [Related]
30. Hypotensive effect of atorvastatin is not related to changes in inflammation and oxidative stress.
Kuklińska AM; Mroczko B; Musiał WJ; Sawicki R; Kozieradzka A; Usowicz-Szaryńska M; Kamiński K; Knapp M; Szmitkowski M
Pharmacol Rep; 2010; 62(5):883-90. PubMed ID: 21098871
[TBL] [Abstract][Full Text] [Related]
31. Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia.
Mazza F; Stefanutti C; Di Giacomo S; Vivenzio A; Fraone N; Mazzarella B; Bucci A
Am J Cardiovasc Drugs; 2008; 8(4):265-70. PubMed ID: 18690760
[TBL] [Abstract][Full Text] [Related]
32. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
Fonseca FA; Ruiz A; Cardona-Muñoz EG; Silva JM; Fuenmayor N; Marotti M;
Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541
[TBL] [Abstract][Full Text] [Related]
33. The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress.
Mulder DJ; van Haelst PL; Wobbes MH; Gans RO; Zijlstra F; May JF; Smit AJ; Tervaert JW; van Doormaal JJ
Cardiovasc Drugs Ther; 2007 Apr; 21(2):91-7. PubMed ID: 17342417
[TBL] [Abstract][Full Text] [Related]
34. Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine.
Bolayirli IM; Aslan M; Balci H; Altug T; Hacibekiroglu M; Seven A
Life Sci; 2007 Jun; 81(2):121-7. PubMed ID: 17532348
[TBL] [Abstract][Full Text] [Related]
35. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
[TBL] [Abstract][Full Text] [Related]
36. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Navarro JF; Mora C; Muros M; García-Idoate G
Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
[TBL] [Abstract][Full Text] [Related]
37. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.
Milionis HJ; Kakafika AI; Tsouli SG; Athyros VG; Bairaktari ET; Seferiadis KI; Elisaf MS
Am Heart J; 2004 Oct; 148(4):635-40. PubMed ID: 15459594
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic association of atorvastatin and insulin in cardiac ischemia: study in a model of type 2 diabetes with hyperlipidemia.
Matafome P; Monteiro P; Nunes E; Louro T; Amaral C; Moedas AR; Gonçalves L; Providência L; Seiça R
Pharmacol Res; 2008; 58(3-4):208-14. PubMed ID: 18692137
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage).
Han KH; Rha SW; Kang HJ; Bae JW; Choi BJ; Choi SY; Gwon HC; Bae JH; Hong BK; Choi DH; Han KR
J Clin Lipidol; 2012; 6(4):340-51. PubMed ID: 22836071
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA
Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
